Rakuten Investment Management Inc. Buys New Position in Agilent Technologies, Inc. $A

Rakuten Investment Management Inc. acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 46,470 shares of the medical research company’s stock, valued at approximately $6,173,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after buying an additional 270 shares in the last quarter. Jones Financial Companies Lllp boosted its position in Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. increased its position in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the period. Acadian Asset Management LLC lifted its stake in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in shares of Agilent Technologies during the second quarter valued at $273,000.

Agilent Technologies Stock Down 2.0%

Agilent Technologies stock opened at $154.47 on Friday. The stock has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.65 and a beta of 1.25. The company has a current ratio of 2.05, a quick ratio of 1.62 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $140.30 and its two-hundred day moving average price is $127.04. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $163.75.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the business posted $1.37 EPS. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Analysts Set New Price Targets

A number of analysts recently weighed in on A shares. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. The Goldman Sachs Group upped their target price on shares of Agilent Technologies from $155.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday. Jefferies Financial Group began coverage on Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Finally, Royal Bank Of Canada boosted their price objective on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.